433 followers
A NEGATIVE trial result adding gemcitabine to standard treatment for high risk early breast cancer. #breastcancer #cancer https://t.co/mo5y7itpFZ
A NEGATIVE trial result adding gemcitabine to standard treatment for high risk early breast cancer. #breastcancer #cancer https://t.co/mo5y7itpFZ
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial | Breast Cancer Research | Full Text https://t.co/hNMcHalneG